Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes

Overview of attention for article published in Frontiers in Aging, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#11 of 377)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 2 news outlets
twitter: 74 X users

reddit: 1 Redditor

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 8 Mendeley

Summary News X Reddit Dimensions citations

So far, Altmetric has seen 3 news stories from 2 outlets.

Cassava Sciences: CMS Data Promising But Many Red Flags Remain; Hold

Seeking Alpha, 10 Aug 2023

Summary Cassava Sciences' core AD treatment candidate simufilam slowed cognitive decline compared to placebo (albeit non-signific…

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer's disease patient lymphocytes.

Alzforum, 21 Jul 2023

Wang HY, Pei Z, Lee KC, Nikolov B, Doehner T, Puente J, Friedmann N, Burns LH. Front Aging.

Why The Market Is Likely Wrong About Cassava Sciences, Again

Seeking Alpha, 07 Jul 2023

Summary Cassava stock crashed in reaction to top-line data from a Phase 2 trial.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.